Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Statistics

Total Valuation

LYEL has a market cap or net worth of $121.09 million. The enterprise value is -$151.95 million.

Market Cap	121.09M
Enterprise Value	-151.95M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

LYEL has 295.34 million shares outstanding. The number of shares has increased by 7.75% in one year.

Current Share Class	295.34M
Shares Outstanding	295.34M
Shares Change (YoY)	+7.75%
Shares Change (QoQ)	+5.41%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	45.53%
Float	191.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,862.90
Forward PS	n/a
PB Ratio	0.36
P/TBV Ratio	0.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.49, with a Debt / Equity ratio of 0.17.

Current Ratio	7.49
Quick Ratio	7.30
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -71.20% and return on invested capital (ROIC) is -25.91%.

Return on Equity (ROE)	-71.20%
Return on Assets (ROA)	-24.40%
Return on Invested Capital (ROIC)	-25.91%
Return on Capital Employed (ROCE)	-56.48%
Revenue Per Employee	$217
Profits Per Employee	-$1.12M
Employee Count	300
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.64% in the last 52 weeks. The beta is -0.26, so LYEL's price volatility has been lower than the market average.

Beta (5Y)	-0.26
52-Week Price Change	-84.64%
50-Day Moving Average	0.47
200-Day Moving Average	0.86
Relative Strength Index (RSI)	43.17
Average Volume (20 Days)	654,669

Short Selling Information

The latest short interest is 5.66 million, so 1.92% of the outstanding shares have been sold short.

Short Interest	5.66M
Short Previous Month	5.64M
Short % of Shares Out	1.92%
Short % of Float	2.96%
Short Ratio (days to cover)	7.97

Income Statement

In the last 12 months, LYEL had revenue of $65,000 and -$334.52 million in losses. Loss per share was -$1.23.

Revenue	65,000
Gross Profit	65,000
Operating Income	-219.45M
Pretax Income	-210.26M
Net Income	-334.52M
EBITDA	-201.40M
EBIT	-219.45M
Loss Per Share	-$1.23

Balance Sheet

The company has $301.18 million in cash and $57.09 million in debt, giving a net cash position of $273.04 million or $0.92 per share.

Cash & Cash Equivalents	301.18M
Total Debt	57.09M
Net Cash	273.04M
Net Cash Per Share	$0.92
Equity (Book Value)	336.52M
Book Value Per Share	1.14
Working Capital	267.89M

Cash Flow

In the last 12 months, operating cash flow was -$175.12 million and capital expenditures -$680,000, giving a free cash flow of -$175.80 million.

Operating Cash Flow	-175.12M
Capital Expenditures	-680,000
Free Cash Flow	-175.80M
FCF Per Share	-$0.60

Margins

Gross Margin	100.00%
Operating Margin	-337,613.85%
Pretax Margin	-514,649.23%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LYEL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.75%
Shareholder Yield	-7.75%
Earnings Yield	-276.26%
FCF Yield	-145.18%

Analyst Forecast

The average price target for LYEL is $1.00, which is 143.84% higher than the current price. The consensus rating is "Sell".

Price Target	$1.00
Price Target Difference	143.84%
Analyst Consensus	Sell
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LYEL has an Altman Z-Score of -3.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.18
Piotroski F-Score	1